rs143443167

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_015512.5(DNAH1):​c.10438A>G​(p.Ile3480Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00176 in 1,613,274 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0010 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 4 hom. )

Consequence

DNAH1
NM_015512.5 missense

Scores

8
9

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3B:1

Conservation

PhyloP100: 2.62

Publications

6 publications found
Variant links:
Genes affected
DNAH1 (HGNC:2940): (dynein axonemal heavy chain 1) This gene encodes an inner dynein arm heavy chain that provides structural support between the radial spokes and the outer doublet of the sperm tail. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and multiple morphological anomalies of the flagella that result in asthenozoospermia and male infertility. Mice with a homozygous knockout of the orthologous gene are viable but have reduced sperm motility and are infertile. [provided by RefSeq, Feb 2017]
DNAH1 Gene-Disease associations (from GenCC):
  • spermatogenic failure 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • ciliary dyskinesia, primary, 37
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.049548).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00101 (153/151756) while in subpopulation NFE AF = 0.00171 (116/67890). AF 95% confidence interval is 0.00146. There are 2 homozygotes in GnomAd4. There are 57 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH1NM_015512.5 linkc.10438A>G p.Ile3480Val missense_variant Exon 65 of 78 ENST00000420323.7 NP_056327.4
DNAH1XM_017006129.2 linkc.10507A>G p.Ile3503Val missense_variant Exon 67 of 80 XP_016861618.1
DNAH1XM_017006130.2 linkc.10438A>G p.Ile3480Val missense_variant Exon 66 of 79 XP_016861619.1
DNAH1XM_017006131.2 linkc.10381A>G p.Ile3461Val missense_variant Exon 66 of 79 XP_016861620.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH1ENST00000420323.7 linkc.10438A>G p.Ile3480Val missense_variant Exon 65 of 78 1 NM_015512.5 ENSP00000401514.2
DNAH1ENST00000486752.5 linkn.10895A>G non_coding_transcript_exon_variant Exon 64 of 77 2
DNAH1ENST00000488988.5 linkn.2224A>G non_coding_transcript_exon_variant Exon 12 of 25 2
DNAH1ENST00000490713.5 linkn.1138A>G non_coding_transcript_exon_variant Exon 8 of 20 5 ENSP00000419071.1

Frequencies

GnomAD3 genomes
AF:
0.00101
AC:
153
AN:
151642
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000461
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000722
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000626
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00171
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000811
AC:
202
AN:
249180
AF XY:
0.000799
show subpopulations
Gnomad AFR exome
AF:
0.000517
Gnomad AMR exome
AF:
0.000493
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000279
Gnomad NFE exome
AF:
0.00141
Gnomad OTH exome
AF:
0.00116
GnomAD4 exome
AF:
0.00184
AC:
2682
AN:
1461518
Hom.:
4
Cov.:
38
AF XY:
0.00177
AC XY:
1288
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.000687
AC:
23
AN:
33478
American (AMR)
AF:
0.000604
AC:
27
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000230
AC:
6
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000243
AC:
21
AN:
86254
European-Finnish (FIN)
AF:
0.000694
AC:
37
AN:
53352
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5766
European-Non Finnish (NFE)
AF:
0.00224
AC:
2492
AN:
1111766
Other (OTH)
AF:
0.00119
AC:
72
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
163
326
490
653
816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00101
AC:
153
AN:
151756
Hom.:
2
Cov.:
32
AF XY:
0.000769
AC XY:
57
AN XY:
74160
show subpopulations
African (AFR)
AF:
0.000460
AC:
19
AN:
41344
American (AMR)
AF:
0.000721
AC:
11
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.000627
AC:
3
AN:
4784
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10564
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00171
AC:
116
AN:
67890
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00151
Hom.:
1
Bravo
AF:
0.000929
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00178
AC:
15
ExAC
AF:
0.000793
AC:
96
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00109
EpiControl
AF:
0.00124

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Uncertain:1
Oct 31, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 3480 of the DNAH1 protein (p.Ile3480Val). This variant is present in population databases (rs143443167, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with DNAH1-related conditions. ClinVar contains an entry for this variant (Variation ID: 478384). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DNAH1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Primary ciliary dyskinesia Uncertain:1
Jan 04, 2018
UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
May 05, 2020
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

DNAH1-related disorder Benign:1
Mar 23, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
21
DANN
Uncertain
1.0
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.92
D
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.050
T
MetaSVM
Benign
-0.41
T
PhyloP100
2.6
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-0.97
N
REVEL
Benign
0.13
Sift
Uncertain
0.020
D
Sift4G
Uncertain
0.021
D
Vest4
0.54
MVP
0.59
MPC
0.36
ClinPred
0.023
T
GERP RS
4.7
gMVP
0.38
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143443167; hg19: chr3-52427005; API